Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.

Müller T.

Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1423-32. doi: 10.1517/17425255.2014.943182. Epub 2014 Sep 6.

PMID:
25196265
[PubMed - in process]
2.

A systematic review of catechol-0-methyltransferase inhibitors: efficacy and safety in clinical practice.

Marsala SZ, Gioulis M, Ceravolo R, Tinazzi M.

Clin Neuropharmacol. 2012 Jul-Aug;35(4):185-90. doi: 10.1097/WNF.0b013e31825c034a. Review.

PMID:
22805229
[PubMed - indexed for MEDLINE]
3.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C.

Mov Disord. 2011 Oct;26 Suppl 3:S2-41. doi: 10.1002/mds.23829. Review.

PMID:
22021173
[PubMed - indexed for MEDLINE]
4.

Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.

Stowe R, Ives N, Clarke CE, Handley K, Furmston A, Deane K, van Hilten JJ, Wheatley K, Gray R.

Mov Disord. 2011 Mar;26(4):587-98. doi: 10.1002/mds.23517. Epub 2011 Mar 2. Review.

PMID:
21370258
[PubMed - indexed for MEDLINE]
5.

Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinson's disease.

Lees AJ.

CNS Neurosci Ther. 2008 Spring;14(1):83-93. doi: 10.1111/j.1527-3458.2007.00035.x. Review.

PMID:
18482101
[PubMed - indexed for MEDLINE]
6.

Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease.

Brooks DJ, Leinonen M, Kuoppamäki M, Nissinen H.

J Neural Transm. 2008 Jun;115(6):843-9. doi: 10.1007/s00702-008-0025-8. Epub 2008 Feb 8.

PMID:
18259682
[PubMed - indexed for MEDLINE]
7.

Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.

Chen JJ, Swope DM, Dashtipour K.

Clin Ther. 2007 Sep;29(9):1825-49. Review.

PMID:
18035186
[PubMed - indexed for MEDLINE]
8.

The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.

Zesiewicz TA, Wecker L, Sullivan KL, Merlin LR, Hauser RA.

Clin Neuropharmacol. 2006 May-Jun;29(3):106-11. Review.

PMID:
16772808
[PubMed - indexed for MEDLINE]
9.

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2006 Apr 11;66(7):983-95. Review.

PMID:
16606909
[PubMed - indexed for MEDLINE]
10.

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.

Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE.

Parkinsonism Relat Disord. 2005 Sep;11(6):381-6.

PMID:
16109498
[PubMed - indexed for MEDLINE]
11.

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004554. Review.

PMID:
15495119
[PubMed - indexed for MEDLINE]
12.

Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004553. Review.

PMID:
15495118
[PubMed - indexed for MEDLINE]
13.

Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.

Olanow CW, Kieburtz K, Stern M, Watts R, Langston JW, Guarnieri M, Hubble J; US01 Study Team.

Arch Neurol. 2004 Oct;61(10):1563-8.

PMID:
15477510
[PubMed - indexed for MEDLINE]
14.

Entacapone.

Chong BS, Mersfelder TL.

Ann Pharmacother. 2000 Sep;34(9):1056-65. Review.

PMID:
10981253
[PubMed - indexed for MEDLINE]
15.

New pharmacotherapy for Parkinson's disease.

Gottwald MD, Bainbridge JL, Dowling GA, Aminoff MJ, Alldredge BK.

Ann Pharmacother. 1997 Oct;31(10):1205-17. Review.

PMID:
9337447
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk